Semaglutide medications like Ozempic and Wegovy have shown proven results for managing conditions like type 2 diabetes and obesity. Also known as GLP-1 agonists, these drugs work by mimicking a ...

Since the approval of Luxturna, there has been a wave of gene therapies advancing in clinical trials to treat genetic vision ...

Jean Mayer United States Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts, USA Background: Recent information suggests that the Age-Related ...

A new study found a link between GLP-1s and a higher risk of neovascular age-related macular degeneration, an eye disease ...

Age-related macular degeneration (AMD) is a major cause of blindness, especially in older adults. A key feature of early AMD ...

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...

The gift will be used to treat and potentially cure eye diseases like macular degeneration and glaucoma, increase focus on ...

Correspondence to Dr F B Sallo, The Reading Centre, Department of Research and Development, Moorfields Eye Hospital, 162 City Road, London EC1V 2PD, UK; fbsallo{at}yahoo.com Aims: To investigate the ...

Jay Chhablani, MD, explains how 3D choroidal vessel segmentation transforms ophthalmology, enhancing disease diagnosis and treatment through advanced imaging technology.

Many eye diseases, such as geographic atrophy ... GA is an advanced form of dry age-related macular degeneration (AMD), which is a leading cause of vision loss among older people.

GLP-1 drugs like Ozempic are associated with a higher risk of developing wet age-related macular degeneration in people with ...

A new study brings into focus the relationship between diabetic GLP-1 users and the elevated risk of age-related eye disease.